“Trastuzumab in Combination with Traditional Chemotherapy is better than Chemotherapy Alone in HER2 Positive Breast Cancer Patients”, TAJ: J of Teachers Assoc, vol. 30, no. 1, pp. 30–35, Dec. 2018, doi: 10.3329/taj.v30i1.39120.